These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 7347105)
41. Platelet MAO concentration and molecular activity: II. Comparison of normal and schizophrenic populations. Rose RM; Castellani S; Boeringa JA; Malek-Ahmadi P; Lankford DA; Bessman JD; Fritz RR; Denney CB; Denney RM; Abell CW Psychiatry Res; 1986 Feb; 17(2):141-51. PubMed ID: 2870529 [TBL] [Abstract][Full Text] [Related]
42. Effect of nomifensine on platelet monoamine oxidase activity in chronic schizophrenic patients. Filinger EJ Gen Pharmacol; 1989; 20(6):821-2. PubMed ID: 2591711 [TBL] [Abstract][Full Text] [Related]
43. Monoamine oxidase (MAO) of platelets, plasma, lymphocytes and granulocytes in schizophrenia. Bond PA; Cundall RL; Falloon IR Br J Psychiatry; 1979 Apr; 134():360-5. PubMed ID: 444786 [TBL] [Abstract][Full Text] [Related]
44. Low platelet MAO activity in chronic schizophrenics: a long-term effect of neuroleptic treatment? Del Vecchio M; Maj M; D'Ambrosio A; Kemali D Psychopharmacology (Berl); 1983; 79(2-3):177-9. PubMed ID: 6133302 [TBL] [Abstract][Full Text] [Related]
45. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. I. Plasma dopamine-beta-hydroxylase activity in endogenous depression. Puzynski S; Rode A; Zaluska M Acta Psychiatr Scand; 1983 Feb; 67(2):89-95. PubMed ID: 6846042 [TBL] [Abstract][Full Text] [Related]
46. Platelet MAO activity in schizophrenia and other psychiatric illnesses. Sullivan J; Stanfield CN; Dackis C Am J Psychiatry; 1977 Oct; 134(10):1098-1103. PubMed ID: 900261 [TBL] [Abstract][Full Text] [Related]
49. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome. Mann J; Thomas KM Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192 [TBL] [Abstract][Full Text] [Related]
50. Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia. Wyatt RJ; Murphy DL Res Publ Assoc Res Nerv Ment Dis; 1975; 54():289-97. PubMed ID: 769116 [No Abstract] [Full Text] [Related]
51. Biochemical genetics of catecholamines in humans. Weinshilboum RM Mayo Clin Proc; 1983 May; 58(5):319-30. PubMed ID: 6843183 [TBL] [Abstract][Full Text] [Related]
52. A biochemical study of tardive dyskinesia in young male patients. Jeste DV; DeLisi LE; Zalcman S; Wise CD; Phelps BH; Rosenblatt JE; Potkin SG; Bridge TP; Wyatt RJ Psychiatry Res; 1981 Jun; 4(3):327-31. PubMed ID: 6115438 [TBL] [Abstract][Full Text] [Related]
53. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders. Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252 [TBL] [Abstract][Full Text] [Related]
54. Schizophrenic outcome in late life: symptom state and platelet monoamine oxidase activity. Bridge TP; Jeste DV; Wise CD; Potkin SG; Phelps BH; Wyatt RJ Psychiatry Res; 1984 Feb; 11(2):91-7. PubMed ID: 6143337 [TBL] [Abstract][Full Text] [Related]
55. Changes in platelet monoamine oxidase and plasma dopamine-beta-hydroxylase activities in lithium-treated bipolar patients. Sofuoğlu S; Doğan P; Köse K; Eşel E; Baştũrk M; Oğuz H; Gönül AS Psychiatry Res; 1995 Nov; 59(1-2):165-70. PubMed ID: 8771233 [TBL] [Abstract][Full Text] [Related]
56. Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia. Yoshimoto S; Kaku H; Shimogawa S; Watanabe A; Nakagawara M; Takahashi R Psychiatry Res; 1987 Jul; 21(3):229-36. PubMed ID: 3628609 [TBL] [Abstract][Full Text] [Related]
57. Platelet MAO activity and family history of schizophrenia. Duncavage M; Luchins DJ; Meltzer HY Psychiatry Res; 1982 Aug; 7(1):47-51. PubMed ID: 6957899 [TBL] [Abstract][Full Text] [Related]